Nasal cell micronuclei, cytology and clinical symptoms in stainless steel production workers exposed to chromium.
The objective of the present study was to determine whether workers in stainless steel production with low exposure to various forms of chromium show an increase in micronucleated nasal cells or an excess of nasal symptoms or disease. Altogether, 48 workers employed in a stainless steel production chain were studied, 29 of them in the steel melting shop with exposure to hexavalent chromium (Cr(6+)), 14 in the sintering and crushing departments of the ferrochromium plant with exposure to trivalent chromium (Cr(3+)) and five in the mine with exposure to chromite ore (Cr(3+)). Thirty-nine workers from the cold rolling mill, with very low exposure to chromium, served as referents. All the subjects were never smokers with a minimum of 14 years employment in the same department. There were no significant differences between the exposure groups and the referents regarding the mean frequency of centromere-negative or centromere-positive micronuclei (studied by pancentromeric fluorescence in situ hybridization), nasal diseases and symptoms or mucociliary clearance of the nasal cavity. No statistically significant differences in the incidence of cell atypia or inflammatory cells were detected between the exposed workers and the reference group, except for an increase in lymphocytes among the chromite ore workers. Anterior rhinoscopy indicated slight inflammatory changes in nasal mucosa and secretion more often in the Cr(6+) and Cr(3+) groups than in the referents, the Cr(6+)-exposed workers showing more livid or oedemic epithelium. In conclusion, the stainless steel production workers, with low exposure to dusts or fumes containing hexavalent or trivalent chromium, did not show clinical changes in the nasal mucosa or an increase in nasal cell micronuclei or symptoms of nasal diseases, except for slight changes in the nasal epithelium and secretion.
Huvinen
Markku
M
Outokumpu Oyj, PO Box 27, FIN-02201 Espoo, Finland. markku.huvinen@autokumpu.com
Mäkitie
Antti
A
Järventaus
Hilkka
H
Wolff
Henrik
H
Stjernvall
Tuula
T
Hovi
Arja
A
Hirvonen
Ari
A
Ranta
Riikka
R
Nurminen
Markku
M
Norppa
Hannu
H
D000328:Adult; D017608:Chromium Compounds / Q000009:adverse effects*; D002869:Chromosome Aberrations; D004391:Dust; D004847:Epithelial Cells / Q000187:drug effects; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D008669:Metallurgy; D048629:Micronuclei, Chromosome-Defective / Q000187:drug effects*; D008875:Middle Aged; D009297:Nasal Mucosa / Q000166:cytology*; D009668:Nose Diseases / Q000139:chemically induced; D009784:Occupational Diseases / Q000139:chemically induced; D016273:Occupational Exposure / Q000009:adverse effects*; D012120:Respiration Disorders / Q000139:chemically induced; D013193:Stainless Steel
D017608:Chromium Compounds; D004391:Dust; D013193:Stainless Steel